Home - Products - Others - Other Targets - Genistein 7-O-β-D-glucopyranoside-4-O-[α-L-rhamnopyranosyl-(1-2)-β-D-glucopyranoside]

Genistein 7-O-β-D-glucopyranoside-4-O-[α-L-rhamnopyranosyl-(1-2)-β-D-glucopyranoside]

CAS No. 361447-29-2

Genistein 7-O-β-D-glucopyranoside-4-O-[α-L-rhamnopyranosyl-(1-2)-β-D-glucopyranoside]( ——— )

Catalog No. M38779 CAS No. 361447-29-2

Genistein 7-O-β-D-glucopyranoside-4’-O-[α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside]

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Genistein 7-O-β-D-glucopyranoside-4-O-[α-L-rhamnopyranosyl-(1-2)-β-D-glucopyranoside]
  • Note
    Research use only, not for human use.
  • Brief Description
    Genistein 7-O-β-D-glucopyranoside-4’-O-[α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside]
  • Description
    Genistein 7-O-β-D-glucopyranoside-4’-O-[α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside]
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    361447-29-2
  • Formula Weight
    740.66
  • Molecular Formula
    C33H40O19
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Contraceptive Tetrap...

    Kentsin, a contraceptive tetrapeptide, is originally extracted from hamster embryos. Kentsin prevents the maturation of Graafian follicles and consequently inhibits ovulation. Kentsin has opiate properties on gastrointestinal motility.

  • SM-102

    SM-102 is an ionizable amino lipid that can be used for the formation of lipid nanoparticles (LNPs). SM-102 has the potential for development of lipid nanoparticles for delivery of mRNA-based vaccines.

  • FMRF

    FMRF is a peptide consisting of 4 amino acid residues.